Motley Rice - Attorneys at Law
Navigation
Main navigation
Motley Rice represents clients across many areas.
Learn about the cases Motley Rice is actively representing clients in or cases that we've litigated previously.
People have filed lawsuits against weight loss drug manufacturers Novo Nordisk and Eli Lilly.
Lawsuits allege talcum powder use is linked to reproductive organ cancer for women.
Individuals who know of an FCA violation can file a qui tam whistleblower lawsuit.
Social media companies are being sued over alleged teenage mental health harms.
This library contains more than 2,000 exhibits cited in social media harm lawsuits across the United States.
Survivors of sexual abuse may hire a civil sexual abuse attorney to discuss what they’ve experienced and look into pursuing legal action.
Studies link hair relaxers to uterine/ovarian cancer. Lawsuits seek to hold companies accountable.
Asbestos-related diseases include mesothelioma, lung cancer and asbestosis.
ERISA sets minimum standards including which employees are eligible for benefits, how benefits must be calculated, and when benefits vest.
While litigation can take years to complete from start to finish, our firm is always working for our clients, no matter how long it takes or how hard it gets.
Motley Rice attorneys and support personnel are dedicated to representing clients and working with co-counsel located throughout the United States and around the world.
Comprehensive, up-to-date news on the issues surrounding the litigation areas of Motley Rice LLC.
Learn about the latest happenings from lawsuits and other events impacting plaintiffs, including the new Social Media Harm Evidence Library.
Read news coverage about Motley Rice, its clients and our efforts to hold defendants accountable.
Motley Rice lawyers share their insights on litigation and more to inform people exploring their legal options.
This case is no longer active
The Legal Team
When companies misrepresent critical information that affects shareholder value, investors and stakeholders can play a valuable role by litigating to help hold the companies accountable and to recover lost investment funds.
In Feb. 2013, the U.S. District Court for the District of New Jersey granted final approval of a $164 million settlement for investors who purchased common stock of Pharmacia Corporation between April 17, 2000, and August 5, 2001.
Motley Rice served as co-class counsel in this federal securities fraud litigation alleging that the defendants, including Pharmacia Corporation, Pfizer Inc. and numerous former executives, misrepresented the results of a 2000 clinical trial involving the gastrointestinal benefits of Celebrex® to make its safety profile appear better than rival drugs. These allegedly misleading statements led to shareholders’ alleged loss of billions.
We applaud our client, PACE Industry Union Industry Management Pension Fund, and the other five class representatives that stepped forward to pursue this important litigation.
Alaska Electrical Pension Fund v. Pharmacia Corp., Consol. No. 03-1519 (AET) (D.N.J.)
Final Judgment and Order of Dismissal with Prejudice (U.S. District Court of New Jersey, Jan. 30, 2013)
If you have questions regarding cases similar to the Alaska Electrical Pension Fund v. Pharmacia Corp settlement or if you would like to discuss a potential case, contact our securities team by email or call 1.800.768.4026.
*Prior results do not guarantee a similar outcome.